Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)

Bibliographic Details
Main Authors:	Riddle, Matthew C., Forst, Thomas, Aronson, Ronnie, Sauque-Reyna, Leobardo, Souhami, Elisabeth, Silvestre, Louise, Ping, Lin, Rosenstock, Julio
Format:	Online
Language:	English
Published:	American Diabetes Association 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747901/

Similar Items

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-week, randomized, placebo-controlled comparison (GetGoal-L)
by: Riddle, Matthew C., et al.
Published: (2013)

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial
by: Rosenstock, Julio, et al.
Published: (2016)

Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M)
by: Ahrén, Bo, et al.
Published: (2013)

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)
by: Rosenstock, Julio, et al.
Published: (2013)

Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of GetGoal-S
by: Onishi, Yukiko, et al.
Published: (2015)

Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial
by: Ratner, R E, et al.
Published: (2010)

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
by: Kapitza, C, et al.
Published: (2013)

The Mobile Insulin Titration Intervention (MITI) for Insulin Glargine Titration in an Urban, Low-Income Population: Randomized Controlled Trial Protocol
by: Levy, Natalie, et al.
Published: (2015)

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)
by: Fonseca, Vivian A., et al.
Published: (2012)

Lixisenatide Improves Glycemic Control in Asian Type 2 Diabetic Patients Inadequately Controlled With Oral Antidiabetic Drugs: An Individual Patient Data Meta-Analysis
by: Shu, Hua, et al.
Published: (2016)

Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month ‘proof-of-concept’ study
by: Owens, D R, et al.
Published: (2011)

Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)*
by: Seino, Y, et al.
Published: (2012)

Evaluation of the efficacy and safety of lixisenatide add-on treatment to basal insulin therapy among T2DM patients with different body mass indices from GetGoal trials
by: Eto, Kazuhiro, et al.
Published: (2015)

Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin
by: Rodbard, H. W., et al.
Published: (2016)

Lixisenatide as add-on therapy to basal insulin
by: Brown, Dominique Xavier, et al.
Published: (2013)

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
by: Petersen, Andreas B, et al.
Published: (2013)

Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice*
by: Hammer, H, et al.
Published: (2007)

Doing Duo – a case study of entrainment in William Forsythe’s choreography “Duo”
by: Waterhouse, Elizabeth, et al.
Published: (2014)

Duo out for camp
by: Syahrina, Ahmad
Published: (2010)

Better Times Ahead For Duo
by: The Star, Y.P.Sivam
Published: (2008)

Duo aim for 2020 championship
by: Peter, Fabian
Published: (2017)

Ometron's DuoScan
Published: (1998)

Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks
by: Diamant, Michaela, et al.
Published: (2012)

A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine
by: Mathieu, Chantal, et al.
Published: (2015)

Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial
by: Rosenstock, Julio, et al.
Published: (2014)

Elated over our duo's win
by: Sitheravellu, C. Sathasivam
Published: (2016)

Machining centre duo for aerospace specialist
Published: (2005)

Dana chooses KUKA robot duo
Published: (2002)

Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials
by: Rosenstock, Julio, et al.
Published: (2016)

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)
by: Bolli, G B, et al.
Published: (2015)

The Clinical Development Program of Lixisenatide: A Once-Daily Glucagon-Like Peptide-1 Receptor Agonist
by: Bain, Stephen C.
Published: (2014)

Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes
by: Home, P D, et al.
Published: (2015)

Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient-level pooled analysis
by: Chaudhuri, Ajay, et al.
Published: (2012)

Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes
by: Barnett, Anthony H
Published: (2011)

Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies
by: Wohlfart, Paulus, et al.
Published: (2013)

Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects
by: Becker, Reinhard H. A., et al.
Published: (2015)

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1)
by: Matsuhisa, M., et al.
Published: (2016)

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2)
by: Terauchi, Y., et al.
Published: (2016)

Gerak tari duo renang berirama pukau juri
by: Harian Metro,
Published: (2017)

Thyroxine and cardiac electrophysiology—a forgotten physiological duo?
by: Ker, James
Published: (2012)